TWiV reviews continuing expansion of poliovirus type 2, removal of influenza B/Yamagata from the vaccine, Nobel Prize for miRNAs, protective immune response with a adenovirus-associated virus vector expressing a computationally designed hemagglutinin, and viral gene drive during herpes simplex 1 infection in mice.
Hosts: Vincent Racaniello, Alan Dove, Rich Condit, Kathy Spindler, and Brianne Barker
Click arrow to play
Download TWiV 1161 (66 MB .mp3, 110 min)
Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email
Become a patron of TWiV!
Links for this episode
Continued expansion of type 2 poliovirus (reliefweb) 4:41
No more polio case map at polioeradication.org 9:35
B/Yamagata removed from flu vaccine (NPR) 10:50
Nobel Prizes for miRNA (ScienceInsider) 15:25
AAV-vectored influenza vaccine (J Virol) 21:45
Herpesvirus type 1 gene drive in mice (Nat Commun) 1:01:54
Timestamps by Jolene. Thanks!
Weekly Picks 1:32:38
Brianne – Virus and Vaccines Information Page from NIH All of Us Research Program
Kathy – For a Pivotal Vaccine: Trial, Error and Two Young Lives
Rich – October 17 2024 APOD: The Clipper and the Comet
Alan – Opening a deep-sea vent with a crowbar
Vincent – The expanding world of neuroscience
Listener Pick
Jason – Solar eclipse on Mars and Polaris Program and their Harmony of Resilience
Ryan – New York’s childhood vaccine coverage remains high
Intro music is by Ronald Jenkees
Send your virology questions and comments to twiv@microbe.tv
Content in this podcast should not be construed as medical advice.
The post TWiV 1161: Baby you can drive my gene first appeared on This Week in Virology.
Merry Christmas to everyone, I hope no one has the flu, cold or pneumonia.
Superb podcast! Does Rous sarcoma virus (RSV) cause cancers in chickens or does cancer in chickens cause RSV? Rous and others couldn’t address this because they lacked the proper scientific tools and because the concept is so weird. Dickson’s comment on the materials being available at Rockefeller is really, really interesting.
RSV and related acutely-transforming chicken oncoviruses are derived from a small, simple retrovirus (ALV) and there really isn’t any room in the genome if an ALV picks up an oncogene like src. Because of this, these viruses generally become replication incompetent. They require intact, nononcogenic helper ALV coinfections to replicate.
Thus, oncogenic ALV that have picked up oncogenes (i.e., RSV, etc.) do not appear to be maintained in wild chicken populations. Imagine that Rous’ cancerous barred Plymouth Rock hen was infected with ALV but the virus did not cause the original tumor. If by chance one ALV growing within the tumor picked up src (or as in Bang-Ellerman’s experiment, a different oncogene, ERBB2), and then, through Rous’ human intervention, was transmitted to a new chicken to cause an entirely new tumor now caused by RSV, we could say that a chicken tumor caused RSV–not the other way around.
Add to this the fact that Rous couldn’t possibly know that each of the chicken’s cells already harbored endogenous retroviruses (proto-oncoviruses, if you will) that possibly might become exogenized during gene derepression in tumor cell growth. On the concept of endogenous retroviruses, which were discovered after he had died, Rous once said: “One can scarcely suppose that a horde of viruses, each with its more or less limited potentialities, are passed along together in the ovum or sperm, as generation succeeds generation, or that they reach the young organism by way of the uterus or milk.” Francis Peyton Rous, 1960 (http://www.ncbi.nlm.nih.gov/pubmed/21102637). These simple retroviral genetic elements are highly similar to ALV and appear to be the origin of the mouse leukemia viruses (and most notoriously, XMRV). It’s enough to make a tumor virologist’s head explode.
Also, these are really good reads. Anyone who hasn’t read Cannery Row (and its sequel, Sweet Thursday), Log from the Sea of Cortez and Travels with Charlie is definitely missing out.
Relevant to this discussion, Rich Condit asked Robin Weiss the following question: “I’m wondering about the defectiveness or non-defectiveness of the original RSV. I’m coming away with the impression that the “original” RSV (were there several isolates or variants?) was heterogeneous at best and contained at least some defective transforming retrovirus. Is this true and do you have any sense as to when or where the non-defective virus arose?
Robin’s answer: The non-defective RSV strains arose in European labs: Schmidt-Ruppin in Zurich, Prague in Prague and Carr-Zilber in Moscow. The common feature appears to be that each of these viruses was rescued from mammalian cells transformed by RSV. Mammalian cells are non-permissive for RSV and ALV replication but they release infectious virus upon fusion with chick cells, as first reported by Svoboda in Prague in 1967. I wonder if a replication-defective virus recombined with an ALV helper virus during this cross-species forced infection, but that is speculation.